The ability to determine vitamin D levels in patients rapidly and reliably is a valuable tool in identification and management of treatment regimes.
The “sunshine vitamin”, vitamin D, is the only vitamin to be manufactured by the human body, being formed on exposure of the skin to sunlight. Even people living in the sunniest climates may not make enough vitamin D. This deficiency can contribute to a whole host of health problems including rickets in children, osteoporosis, cardiovascular disease, diabetes, osteoarthritis and many forms of cancer. Vitamin D deficiency is increasingly common amongst the general population, which is leading to a significant growth in the need for determination of 25-hydroxy vitamin D, also known as 25(OH)D, in blood serum. As such, the ability to determine vitamin D levels in patients rapidly and reliably is a valuable tool in identification and management of treatment regimes.
Vitamin D, see Figure 1, refers to vitamin D3 (cholecalciferol), the form that is synthesized in the skin by exposure to sunlight and to vitamin D2 (ergocalciferol), which is obtained from the ultraviolet irradiation of plant materials and is the most common form of vitamin D used in prescription supplements. Natural sources of vitamin D3 include oily fish (such as salmon or mackerel), cod liver oil and fortified food (such as milk, orange juice, butter, cheese and breakfast cereals). Prescription vitamin D preparations contain ergocalciferol, vitamin D2 (50 000 IU/capsule), while over-the-counter supplements contain cholecalciferol, D3 (400, 800, 1000 and 2000 IU/capsule).
When patients are being treated specifically with vitamin D2 it is highly desirable to be able to differentiate between the two forms of the vitamin to determine the efficacy of the dosage. In the body the vitamin is tightly bound to a transport protein so sample preparation must be able to separate 25(OH)D from its carrier proteins.
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.